These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14509533)

  • 1. Immunosuppression in hepatitis B virus and hepatitis C virus transplants: special considerations.
    Samuel D; Kimmoun E
    Clin Liver Dis; 2003 Aug; 7(3):667-81. PubMed ID: 14509533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
    Eghtesad B; Fung JJ; Demetris AJ; Murase N; Ness R; Bass DC; Gray EA; Shakil O; Flynn B; Marcos A; Starzl TE
    Liver Transpl; 2005 Nov; 11(11):1343-52. PubMed ID: 16237712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New era of liver transplantation for hepatitis B: a 17-year single-center experience.
    Anselmo DM; Ghobrial RM; Jung LC; Weaver M; Cao C; Saab S; Kunder G; Chen PW; Farmer DG; Yersiz H; Baquerizo A; Geevarghese S; Han SH; Goldstein L; Holt CD; Gornbein JA; Busuttil RW
    Ann Surg; 2002 May; 235(5):611-9; discussion 619-20. PubMed ID: 11981206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.
    Ben-Ari Z; Ashur Y; Daudi N; Shmilovitz-Wiess H; Brown M; Sulkes J; Klein A; Mor E; Tur-Kaspa R; Shouval D
    Clin Transplant; 2004 Aug; 18(4):415-22. PubMed ID: 15233819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents.
    Juan J; Feld JJ
    Curr Opin Rheumatol; 2014 Jul; 26(4):395-403. PubMed ID: 24841230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
    Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A
    Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-drug interactions--molecular insight into immunosuppression and HCV.
    Pan Q; Tilanus HW; Metselaar HJ; Janssen HL; van der Laan LJ
    Nat Rev Gastroenterol Hepatol; 2012 Apr; 9(6):355-62. PubMed ID: 22508161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study.
    Lladó L; Fabregat J; Castellote J; Ramos E; Xiol X; Torras J; Serrano T; Baliellas C; Figueras J; Garcia-Gil A; Rafecas A;
    Liver Transpl; 2008 Dec; 14(12):1752-60. PubMed ID: 19025919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
    Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
    Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma.
    Fan ST; Cheung ST; Lo CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E181-6. PubMed ID: 10921405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.
    Wang ZX; Ding GS; Fu H; Zhang JJ; Chen XS; Guo WY; Shi XM; Fu ZR
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):345-8. PubMed ID: 15313666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin.
    Buti M; Tabernero D; Mas A; Homs M; Prieto M; Rodríguez-Frías F; Casafont F; Casillas R; González A; Miras M; Herrero JI; Castells L; Esteban R
    Transpl Infect Dis; 2015 Apr; 17(2):208-20. PubMed ID: 25641570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of virologically compromised organs in liver transplantation.
    Rodriguez-Luna H; Arenas J; Vargas HE
    Clin Liver Dis; 2003 Aug; 7(3):573-84, vi. PubMed ID: 14509527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.
    Klintmalm GB; Davis GL; Teperman L; Netto GJ; Washburn K; Rudich SM; Pomfret EA; Vargas HE; Brown R; Eckhoff D; Pruett TL; Roberts J; Mulligan DC; Charlton MR; Heffron TG; Ham JM; Douglas DD; Sher L; Baliga PK; Kinkhabwala M; Koneru B; Abecassis M; Millis M; Jennings LW; Fasola CG
    Liver Transpl; 2011 Dec; 17(12):1394-403. PubMed ID: 21850690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis C infection before and after liver transplantation.
    Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
    World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update in liver transplantation in patients with hepatitis B and hepatitis C.
    Montalbano M; Neff GW
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):109-26. PubMed ID: 15756150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.